Skip to main content
70°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Irwin Naturals Inc
(OP:
IWINF
)
0.5000
UNCHANGED
Last Price
Updated: 9:33 AM EDT, Aug 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Irwin Naturals Inc
< Previous
1
2
3
Next >
Irwin Naturals Sued By East West Bank Over $40M Loan Default
August 13, 2024
Irwin Naturals faces a $40M loan lawsuit from East West Bank, leading to Chapter 11 bankruptcy. Explore the implications for the supplements company and its investors.
Via
Benzinga
Topics
Bankruptcy
Lawsuit
Exposures
Financial
Legal
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
December 05, 2023
Defense Dept. Funds Ketamine Study For PTSD Treatment
Via
Benzinga
Irwin Naturals' Bold Leap: Cannabis, Psychedelics Drive Q3 Buzz Despite Falling Revenue & Surging Losses
November 28, 2023
Irwin Naturals Inc.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
September 05, 2023
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety
Via
Benzinga
Irwin Naturals Launches Trio Of Cannabis Tinctures In California
July 28, 2023
Irwin Naturals Inc.
Via
Benzinga
Irwin Naturals Revenue Sluggish In Q2, Net Loss Grows YOY
August 28, 2023
Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) reported its financial results for the second quarter of fiscal 2023, the period ended June 30, revealing a slight year-over-year improvement in...
Via
Benzinga
Cannabis Stock Gainers And Losers From August 25, 2023
August 25, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Irwin Naturals Q1 FY23 Revenue Stagnates YoY, What About Adjusted EBITDA?
June 01, 2023
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA: 97X) released its financial results for the first quarter and year ended March 31, 2023, revealing revenue of $22.5 million, down 0.4% from $22.6...
Via
Benzinga
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
August 17, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More
May 31, 2023
Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study Australian psychedelics company MindBio Therapeutics Corp. was granted approval by both the Ethics...
Via
Benzinga
Marijuana Stock Movers For August 15, 2023
August 15, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Irwin Naturals FY22 Revenue Declines 10.8%, What About Adjusted EBITDA?
May 26, 2023
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) revenue in 2022 was $89.5 million, down 10.8% from $100.3 million in 2021.
Via
Benzinga
Cannabis Stock Movers For August 10, 2023
August 10, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
May 08, 2023
EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations
Via
Benzinga
Cannabis Scandal And Resignation Of Oregon Official, USCC's New Leadership & More Executive Moves
May 05, 2023
New Team Of Top Executives And Experts To Lead USCC Amid Possible Cannabis Policy Reform
Via
Benzinga
Cannabis Stock Movers For July 27, 2023
July 27, 2023
Via
Benzinga
Psychedelics Company Confirms Shares Spinout, Another Fails To File Financials & Gets CTO Issue
May 03, 2023
Blackhawk and MindBio Complete Plan Of Arrangement, Shares Spinout
Via
Benzinga
Cantor Fitzgerald Discontinues Research Coverage Of The Cannabis Sector
May 01, 2023
Cantor Fitzgerald has transferred coverage of WM Technology (NASDAQ: MAPS) to Brett Knoblauch.
Via
Benzinga
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
March 27, 2023
Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses
Via
Benzinga
Irwin Naturals Cannabis Products Launch Nationwide In Canada
March 24, 2023
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) announced the release of Irwin Naturals Cannabis’ new CBD 25mg Softgels in Canada, available nationwide through the Starseed Medicinal Medical...
Via
Benzinga
Irwin Naturals Acquires Ketamine Media
March 22, 2023
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA: 97X) acquired Keta Media, LLC, dba Ketamine Media.
Via
Benzinga
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
March 20, 2023
Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered
Via
Benzinga
Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal
March 16, 2023
Irwin Naturals Inc.
Via
Benzinga
In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend?
March 15, 2023
Closely following the announcement of what's to become of the new regulations for telehealth, including ketamine therapy, several of in-clinic treatment centers have announced they are closing their...
Via
Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
March 06, 2023
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.
Via
Benzinga
Braxia Scientific's Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals
March 02, 2023
Research and telemedicine company Braxia Scientific Corp. (OTC: BRAXF) has filed its financial statements for the third quarter ended Dec.
Via
Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
February 27, 2023
Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and...
Via
Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and...
Via
Benzinga
Irwin Naturals Acquires Ketamine Clinic In Kentucky Adding $3M In Projected EBITDA
February 21, 2023
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) has successfully completed the acquisition of Serenity Health, LLC, a ketamine clinic in Louisville, KY. The agreement with Serenity was...
Via
Benzinga
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
February 06, 2023
Australian Health Authority To Allow Psilocybin And MDMA-Assisted Therapy For Depression, PTSD Beginning on July 1, 2023, medicines containing psilocybin and MDMA can be prescribed by specifically...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.